Eurasian Hematology-Oncology Group

http://www.ehog.net/

 

118 views
October 6, 2024

Chapters

Continuous BTK Therapy & CLL Treatment Evolution

00:00

Finite Therapy Prospects & Subgroup Analysis

04:10

Comparing Continuous BTK & VEN-G in High-Risk Patients

06:33

Ongoing Trials & Moving Toward Time-Limited Therapy

08:36

0 Comments
Login to view comments. Click here to Login